{"id":424007,"date":"2025-09-28T15:19:10","date_gmt":"2025-09-28T15:19:10","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/424007\/"},"modified":"2025-09-28T15:19:10","modified_gmt":"2025-09-28T15:19:10","slug":"un-traitement-preventif-bientot-disponible-a-bas-cout-dans-120-pays-liberation","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/424007\/","title":{"rendered":"un traitement pr\u00e9ventif bient\u00f4t disponible \u00e0 bas co\u00fbt dans 120 pays \u2013 Lib\u00e9ration"},"content":{"rendered":"<p class=\"sc-cPiKLX AiZTS text-element\">Les g\u00e9n\u00e9riques du Lenacapavir, <a href=\"https:\/\/www.liberation.fr\/societe\/sante\/vih-ce-quil-faut-savoir-sur-le-lenacapavir-nouveau-traitement-preventif-20240801_QLWSHAJWAVGXFI3L6YRA7ZYYMU\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.liberation.fr\/societe\/sante\/vih-ce-quil-faut-savoir-sur-le-lenacapavir-nouveau-traitement-preventif-20240801_QLWSHAJWAVGXFI3L6YRA7ZYYMU\/\">premier traitement pr\u00e9ventif injectable \u00e0 longue dur\u00e9e d\u2019action contre le VIH<\/a>, devraient \u00eatre commercialis\u00e9s dans 120 pays \u00e0 forte incidence \u00e0 partir de 2027 et pour le prix de 40 dollars par an. Un co\u00fbt tr\u00e8s bas et une protection s\u00fbre \u00e0 presque 100 % qui permet aux scientifiques d\u2019\u00e9tudier de nouvelles pistes de recherche pour lutter contre le virus. Pour Jane Deuve, directrice scientifique de Sidaction, cette avanc\u00e9e est un signe que les travaux des laboratoires sont en bonne voie. <\/p>\n<p class=\"sc-cPiKLX AiZTS text-element\"><b>En quoi le m\u00e9dicament \u00e0 base de Lenacapavir repr\u00e9sente une perspective encourageante dans la lutte contre le VIH ?<\/b><\/p>\n<p class=\"sc-cPiKLX AiZTS text-element\">Il s\u2019agit d\u2019un nouveau traitement pr\u00e9ventif, ce que l\u2019on appelle <a href=\"https:\/\/www.liberation.fr\/societe\/sante\/dans-la-lutte-contre-le-sida-la-prep-encore-trop-peu-accessible-20210511_P5HEF4LTARDMJGKUMWGL2SQ3SA\/\" target=\"_blank\" rel=\"nofollow noopener\" title=\"https:\/\/www.liberation.fr\/societe\/sante\/dans-la-lutte-contre-le-sida-la-prep-encore-trop-peu-accessible-20210511_P5HEF4LTARDMJGKUMWGL2SQ3SA\/\">une Prep<\/a>. Le but ici n\u2019est pas de gu\u00e9rir les malades du sida, mais de permettre aux personnes qui sont expos\u00e9es \u00e0 l\u2019infection <\/p>\n","protected":false},"excerpt":{"rendered":"Les g\u00e9n\u00e9riques du Lenacapavir, premier traitement pr\u00e9ventif injectable \u00e0 longue dur\u00e9e d\u2019action contre le VIH, devraient \u00eatre commercialis\u00e9s&hellip;\n","protected":false},"author":2,"featured_media":424008,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[1011,27,72,71,10705],"class_list":{"0":"post-424007","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-sante","8":"tag-fr","9":"tag-france","10":"tag-health","11":"tag-sante","12":"tag-vih"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115282599278579440","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/424007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=424007"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/424007\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/424008"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=424007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=424007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=424007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}